Concepedia

Publication | Closed Access

Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia

DOI

38

Citations

0

References

2022

Year

Nicholas J. Short, Courtney D. DiNardo, Naval Daver, Walid Macaron, Musa Yılmaz, Gautam Borthakur, Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero, Ghayas C. Issa, Koji Sasaki,
Blood

No additional data available for this publication yet. Check back later!